Chinese investment in the UK’s leading companies has surged to almost £90bn amid fears that Beijing is buying up Britain.

A new global study led by GlaxoSmithKline has found that a single dose of the RSV vaccine Arexvy (RSVPreF3 OA) offers strong ...

Glaxosmithkline Pharmaceuticals Ltd, Marico Ltd, Caplin Point Laboratories Ltd and Aarti Pharmalabs Ltd are among the other losers in the BSE's 'A' group today, 21 April 2025.

GSK plc (LSE/NYSE: GSK) has today released global survey data showing that over half (52%) of people aged 50-60 feel younger than their age—and nearly a fifth (19%) feel as much as a decade younger.

Highlights 54.8% Total Stockholder Return Under Refreshed Board and Management TeamZevra Continues Growth Trajectory into a ...

France, long recognized as a global leader in cosmetic innovation and export, plays a pivotal role in the retinoid market. The French retinoid industry is growing at the fastest pace in Europe, with a ...

GlaxoSmithKline recently held a high-level scientific conference in conjunction with the launch of “Bexsero,” the first ...

In a report released today, Emily Field from Barclays maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target of £14.50. The company’s shares ...

China has been quietly increasing its hold on some of the UK’s most valuable companies. According to recent research, Chinese ...

Canada is just emerging from another winter wave of multiple infectious diseases only for the population to be confronted ...

Researchers from GlaxoSmithKline have reported that a single dose of the RSV vaccine, Arexvy (RSVPreF3 OA), provides ...

Me’s debacle should be a major wake-up call, reminding policymakers and all of us of the risks of giving access to our ...